Table 4.
Matched adjusted odds ratios (aOR) of death with COVID-19 for study patients (N = 1029) with combinations of underlying medical conditions—New York City, March 13–April 9, 2020
| Condition combinations1 | Cases (n = 343) |
Controls (n = 686) |
Matched aOR2 (95% CI) |
|---|---|---|---|
| Heart disease3 and diabetes—n (%) | |||
| Both | 168 (49.0) | 218 (31.8) | 3.13 (2.11, 4.62) |
| Heart disease only | 91 (26.5) | 198 (28.9) | 1.97 (1.30, 2.97) |
| Diabetes only | 24 (7.0) | 32 (4.7) | 2.57 (1.33, 4.98) |
| Neither | 60 (17.5) | 238 (34.7) | Reference |
| Hypertension and diabetes—n (%) | |||
| Both | 156 (45.5) | 195 (28.4) | 2.98 (2.06, 4.30) |
| Hypertension only | 76 (22.2) | 156 (22.7) | 1.88 (1.25, 2.81) |
| Diabetes only | 36 (10.5) | 55 (8.0) | 2.13 (1.25, 3.63) |
| Neither | 75 (21.9) | 280 (40.8) | Reference |
| Hypertension and obesity—n (%) | |||
| Both | 151 (44.0) | 200 (29.2) | 2.90 (1.94, 4.32) |
| Hypertension only | 81 (23.6) | 151 (22.0) | 2.06 (1.35, 3.15) |
| Obesity only | 58 (16.9) | 146 (21.3) | 1.57 (0.99, 2.48) |
| Neither | 53 (15.5) | 189 (27.6) | Reference |
| Obesity and diabetes—n (%) | |||
| Both | 124 (36.2) | 150 (21.9) | 2.91 (1.98, 4.28) |
| Obesity only | 85 (24.8) | 196 (28.6) | 1.68 (1.13, 2.49) |
| Diabetes only | 68 (19.8) | 100 (14.6) | 2.32 (1.49, 3.63) |
| Neither | 66 (19.2) | 240 (35.0) | Reference |
| Hypertension and kidney disease4—n (%) | |||
| Both | 74 (21.6) | 64 (9.3) | 3.81 (2.43, 5.98) |
| Hypertension only | 158 (46.1) | 287 (41.8) | 1.81 (1.31, 2.51) |
| Kidney disease only | 5 (1.5) | 7 (1.0) | 2.10 (0.54, 8.18) |
| Neither | 106 (30.9) | 328 (47.8) | Reference |
| Obesity and kidney disease4—n (%) | |||
| Both | 49 (14.3) | 40 (5.8) | 3.57 (2.17, 5.88) |
| Obesity only | 160 (46.6) | 306 (44.6) | 1.63 (1.19, 2.24) |
| Kidney disease only | 30 (8.7) | 31 (4.5) | 2.84 (1.56, 5.16) |
| Neither | 104 (30.3) | 309 (45.0) | Reference |
1Conditions listed in descending order of prevalence among case-patients
2Adjusted for sex, marital status, and insurance status. Bold-faced aORs indicate significance at alpha=0.05
3Includes history of heart attack, congestive heart failure, coronary artery disease, hypertension, hyperlipidemia, congenital heart disease, valvular heart disease, and other chronic heart conditions (such as angina, arrhythmias, cardiomyopathy, and pulmonary hypertension)
4Includes chronic kidney conditions (such chronic kidney disease, glomerulonephritis, and polycystic kidney disease)